ARCHIVES

Intense Therapies Better Than Lower Dose For AML

This article is from The Cancer Letter archive.

Vol. 27 No. 11 | November 26, 2004

Download PDF Visit The Full Archive

Related Articles

Herceptin Recommended As Adjuvant For HER2 Positive Early Breast Cancer

May 27, 2005

NCI Advisors Set SPORE Review Criteria, Approve Plan To Fund New Ovarian Grant

June 26, 1998

DCPC Suggest Options For Encouraging New Minority Centers

May 4, 1984

Aventis, MediGene In Pact For Development Of Vaccine.

February 25, 2000

In Brief: ACS to Spend Record $85 Million On Research: AACR To Honor Hanafusa, DeVita, Barbacid

March 14, 1986

HOP Development Proceeding Guidelines For New, Revision Of Existing Control Grants Being Written

July 24, 1981